Skip navigation


Real-Time Benefit Check & ePrior Authorization
Analytical Procedures & Methods Validation Europe
Featured Events
CBI Blog

Launching an Orphan Drug: A Case Study by AmerisourceBergen
Sabrina Delio   (Dec 9, 2016) To launch an orphan drug, a manufacturer must overcome unique commercialization challenges, while navigating critical product access scenarios that exist most acutely for small patient populations. Read how one manufacturer ensured that its life-changing therapy would reach patients in need the moment it was first available—and what other manufacturers can learn from this manufacturer’s experiences. [Con't...]

See all CBI blog posts >>